Welcome to LookChem.com Sign In|Join Free

CAS

  • or

693-98-1

Post Buying Request

693-98-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

693-98-1 Usage

Chemical Properties

2-Methylimidazole is a white to light yellow crystalline powder with an amine-like odor. It is highly soluble in polar organic solvents. Insoluble in ether and cold benzene, easily soluble in water, alcohols and ketones. Irritating to skin and mucous membranes. Mice orally LD50 1400mg/kg.

Uses

Different sources of media describe the Uses of 693-98-1 differently. You can refer to the following data:
1. 2-Methylimidazole is a monomethylated imidazole that can be used as a building block in the preparation of a wide range of biologically active compounds. 2-Methylimidazole as well as other imidazoles can be use as catalyst for refolding of enhanced coloured fluorescent protein. 2-Methylimidazole has been identified as a byproduct of fermentation and is detected in foods and mainstream and side-str eam tobacco smoke.
2. 2-Methylimidazole is used as a raw material for the preparation of nitroimidazole antibiotics, which is useful in combat anaerobic bacterial and parasitic infections. It acts as a ligand in coordination chemistry. It is also employed as a hardener or accelerator for epoxy resin and auxiliary agent for textile dyes. Further, it acts as a catalyst for refolding of enhanced colored fluorescent protein. It is also useful as a building block in the synthesis of biologically active compounds. In addition to this, it is used as an active pharmaceutical ingredient intermediate such as metronidazole and dimetridazole.

Preparation

2-Methylimidazole is prepared by condensation of glyoxal, ammonia and acetaldehyde, a Radziszewski reaction. It is widely used as a polymeriza tion cross-linking accelerator and a hardener for epoxy resin systems for semiconductor potting compounds and soldering masks. It is obtained by eliminating dehydrogenation of 2-methylimidazoline. 2-methylimidazoline heated to melt (melting point 107 ℃), carefully add active nickel, raise the temperature to 200-210 ℃ reaction 2h. cool down to below 150 ℃, add water to dissolve, while hot pressure filtration, separation of active nickel, the filter lookchem liquid concentrated to a temperature of 140 ℃ or more, put the material cooling that 2-methylimidazole. Use the method to produce purity of ≥ 98% of the product, 1t product consumption of ethylenediamine (95%) 1095kg, acetonitrile 975kg. better method is to use glyoxal and aldehyde as raw materials.

General Description

It is a white or colorless solid that is highly soluble in polar organic solvents and water. It is a precursor to a range of drugs and is a ligand in coordination chemistry.

Hazard

Possible carcinogen.

Flammability and Explosibility

Notclassified

Purification Methods

Recrystallise 2-methylimidazole from *benzene or pet ether. The picrate has m 215o (from H2O). [Beilstein 23 III/IV 594, 23/5 V 35.]

Check Digit Verification of cas no

The CAS Registry Mumber 693-98-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,9 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 693-98:
(5*6)+(4*9)+(3*3)+(2*9)+(1*8)=101
101 % 10 = 1
So 693-98-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H6N2/c1-4-5-2-3-6-4/h2-3H,1H3,(H,5,6)

693-98-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17063)  2-Methylimidazole, 97%   

  • 693-98-1

  • 100g

  • 194.0CNY

  • Detail
  • Alfa Aesar

  • (A17063)  2-Methylimidazole, 97%   

  • 693-98-1

  • 500g

  • 622.0CNY

  • Detail
  • Alfa Aesar

  • (A17063)  2-Methylimidazole, 97%   

  • 693-98-1

  • 2500g

  • 2484.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1181)  2-Methylimidazole (Ondansetron Impurity F)  pharmaceutical secondary standard; traceable to PhEur

  • 693-98-1

  • PHR1181-500MG

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001320)  OndansetronimpurityF  European Pharmacopoeia (EP) Reference Standard

  • 693-98-1

  • Y0001320

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (02736)  2-Methylimidazole  ≥95.0% (HPLC), pharmaceutical impurity standard

  • 693-98-1

  • 02736-50MG

  • 2,574.00CNY

  • Detail
  • Aldrich

  • (M50850)  2-Methylimidazole  99%

  • 693-98-1

  • M50850-100G

  • 270.27CNY

  • Detail
  • Aldrich

  • (M50850)  2-Methylimidazole  99%

  • 693-98-1

  • M50850-500G

  • 808.47CNY

  • Detail

693-98-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methylimidazole

1.2 Other means of identification

Product number -
Other names Denka CN 25

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:693-98-1 SDS

693-98-1Synthetic route

N-benzyl-2-methylimidazole
13750-62-4

N-benzyl-2-methylimidazole

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With triethylsilane; palladium 10% on activated carbon In tetrahydrofuran at 20℃; for 24h; Inert atmosphere;97%
With potassium tert-butylate; oxygen; dimethyl sulfoxide at 0℃; for 0.25h;85%
With ammonia; sodium
lysidine
534-26-9

lysidine

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With sodium periodate; [N,N'-bis(salicylidene)-o-phenylenediaminato]manganese(III) chloride In water; acetonitrile at 20℃; for 0.416667h;93%
With aluminum oxide; potassium permanganate In acetonitrile at 20℃; for 0.25h;92%
With sodium periodate; (5,10,15,20-tetraphenylporphyrinato)manganese(III) chloride In water; acetonitrile at 20℃; for 5h;92%
2-bromo-1H-imidazole
16681-56-4

2-bromo-1H-imidazole

Trimethylboroxine
823-96-1

Trimethylboroxine

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With C70H40Cl2F68N2O6Pd2; tetrabutylammomium bromide; potassium carbonate In water at 140℃; for 0.416667h; Suzuki-Miyaura reaction; Microwave irradiation;93%
Glyoxal
131543-46-9

Glyoxal

ammonia
7664-41-7

ammonia

isobutyraldehyde
78-84-2

isobutyraldehyde

methylamine
74-89-5

methylamine

A

2-isopropyl-1-methyl-1(H)-imidazole
22509-02-0

2-isopropyl-1-methyl-1(H)-imidazole

B

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
Stage #1: ammonia; isobutyraldehyde; methylamine In methanol; water at 25℃; for 1h;
Stage #2: Glyoxal; ammonia at 25℃; for 1h;
A 88%
B 3%
Glyoxal
131543-46-9

Glyoxal

acetaldehyde
75-07-0

acetaldehyde

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With ammonium bicarbonate In water at 15 - 30℃; for 0.0208333h; Temperature; Microwave irradiation;87.1%
With ammonium hydroxide at 20℃; for 2h;8.9 g
at 0 - 25℃; for 24h;
Glyoxal
131543-46-9

Glyoxal

acetaldehyde
75-07-0

acetaldehyde

methylamine
74-89-5

methylamine

A

1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

B

1,2-dimethyl-1H-imidazole
1739-84-0

1,2-dimethyl-1H-imidazole

C

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With ammonium hydroxide In water at 25 - 70℃; under 225023 Torr; Pressure; Temperature;A 6.27%
B 85.1%
C 6.59%
(3aα,4α,7α,7aα)-2-methyl-3a,4,7,7a-tetrahydro-4,7-methano-1H-benzimidazole

(3aα,4α,7α,7aα)-2-methyl-3a,4,7,7a-tetrahydro-4,7-methano-1H-benzimidazole

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
In decalin at 195℃; for 2h;79%
piperazine
110-85-0

piperazine

A

1H-imidazole
288-32-4

1H-imidazole

B

1,4-pyrazine
290-37-9

1,4-pyrazine

C

1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

D

2-Methylpyrazine
109-08-0

2-Methylpyrazine

E

2-ethylpyrazine
13925-00-3

2-ethylpyrazine

F

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
Pt-Al2O3-In2O3-Re at 400℃; Product distribution; variation of catalyst, temperature;A n/a
B 78.7%
C n/a
D 1.6%
E 3.5%
F n/a
1,4-di-tert-butyl-1,4-diazabutadiene
28227-42-1, 30834-74-3

1,4-di-tert-butyl-1,4-diazabutadiene

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
In diethyl ether at 800℃; under 0.0003 Torr;67%
acetic acid methyl ester
79-20-9

acetic acid methyl ester

ethylenediamine
107-15-3

ethylenediamine

A

lysidine
534-26-9

lysidine

B

1-ethyl-2-methylimidazole
21202-52-8

1-ethyl-2-methylimidazole

C

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
Pt/Al2O3 at 400℃; under 760 Torr;A 7%
B 10.5%
C 62.5%
acetic acid methyl ester
79-20-9

acetic acid methyl ester

ethylenediamine
107-15-3

ethylenediamine

A

lysidine
534-26-9

lysidine

B

1,2-dimethyl-1H-imidazole
1739-84-0

1,2-dimethyl-1H-imidazole

C

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
Pt/Al2O3 at 400℃; under 760 Torr;A 6.6%
B 15.2%
C 61.1%
Pt/Al2O3 at 360℃; under 760 Torr;A 15.5%
B 9%
C 58.5%
Pt/Al2O3 at 360℃; under 760 Torr; Product distribution; var. temp.;
1,4-diisopropyl-1,4-diazabuta-1,3-diene
28227-41-0, 24764-90-7

1,4-diisopropyl-1,4-diazabuta-1,3-diene

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
In diethyl ether at 800℃; under 0.0003 Torr;43%
Glyoxal
131543-46-9

Glyoxal

(S)-2-Amino-1-phenyl-1-ethanol
56613-81-1

(S)-2-Amino-1-phenyl-1-ethanol

acetaldehyde
75-07-0

acetaldehyde

A

(S)-2-(1H-imidazol-1-yl)-1-phenylethanol

(S)-2-(1H-imidazol-1-yl)-1-phenylethanol

B

(S)-2-(2-Methyl-imidazol-1-yl)-1-phenyl-ethanol

(S)-2-(2-Methyl-imidazol-1-yl)-1-phenyl-ethanol

C

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With ammonium acetate In methanol; water for 5h; Heating;A n/a
B 41%
C n/a
(S)-valinol
2026-48-4

(S)-valinol

Glyoxal
131543-46-9

Glyoxal

acetaldehyde
75-07-0

acetaldehyde

A

(S)-3-Methyl-2-(2-methyl-imidazol-1-yl)-butan-1-ol
909026-22-8

(S)-3-Methyl-2-(2-methyl-imidazol-1-yl)-butan-1-ol

B

2-methylimidazole
693-98-1

2-methylimidazole

C

1-[(2S)-1-methoxy-3-methylbutan-2-yl]-1H-imidazole
497830-20-3

1-[(2S)-1-methoxy-3-methylbutan-2-yl]-1H-imidazole

Conditions
ConditionsYield
With ammonium acetate In methanol; water for 5h; Heating;A 34%
B n/a
C n/a
ethyleneimine
151-56-4

ethyleneimine

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With zinc oxide-chromium oxide-iron oxide-aluminium oxide; ammonia; hydrogen at 400℃;
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
beim Gluehen der Zinkchlorid-Doppelsalze mit Calciumoxyd;
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

A

2-methylimidazole
693-98-1

2-methylimidazole

B

hydrogen cyanide
74-90-8

hydrogen cyanide

Conditions
ConditionsYield
beim Durchleiten durch ein rotgluehendes Rohr;
beim Durchleiten durch ein rotgluehendes Rohr;
1-ethyl-2-methylimidazole
21202-52-8

1-ethyl-2-methylimidazole

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
beim Gluehen der Zinkchlorid-Doppelsalze mit Calciumoxyd;
1-ethyl-2-methylimidazole
21202-52-8

1-ethyl-2-methylimidazole

A

2-methylimidazole
693-98-1

2-methylimidazole

B

hydrogen cyanide
74-90-8

hydrogen cyanide

Conditions
ConditionsYield
beim Durchleiten durch ein gluehendes Rohr;
2-methyl-1,3-oxazol-4-carboxylic acid
23012-17-1

2-methyl-1,3-oxazol-4-carboxylic acid

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With ammonium hydroxide at 150℃;
5-chloro-1-ethyl-2-methyl-1H-imidazole
4897-22-7

5-chloro-1-ethyl-2-methyl-1H-imidazole

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
beim Gluehen der Zinkchlorid-Doppelsalze mit Calciumoxyd;
2-Methylimidazole-4,5-dicarboxylic acid
5313-35-9

2-Methylimidazole-4,5-dicarboxylic acid

2-methylimidazole
693-98-1

2-methylimidazole

Glyoxal
131543-46-9

Glyoxal

2,4,6-trimethyl-hexahydro-[1,3,5]triazine; trihydrate
58052-80-5, 76231-37-3

2,4,6-trimethyl-hexahydro-[1,3,5]triazine; trihydrate

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With water
In water-d2 for 0.00555556h; Sonication;
acetic acid
64-19-7

acetic acid

ethylenediamine
107-15-3

ethylenediamine

2-methylimidazole
693-98-1

2-methylimidazole

Conditions
ConditionsYield
With hydrogen; Pt/Al2O3; AP-64K platinum-alumina catalyst at 400℃;
With aluminium oxide contact; Pt/Al2O3; hydrogen at 430 - 440℃;
lysidine
534-26-9

lysidine

A

1-ethyl-2-methylimidazole
21202-52-8

1-ethyl-2-methylimidazole

B

2-methylimidazole
693-98-1

2-methylimidazole

C

monoacetylaminoethylamine
1001-53-2

monoacetylaminoethylamine

D

1-ethyl-2-methyl-4,5-dihydro-1H-imidazole
4814-93-1

1-ethyl-2-methyl-4,5-dihydro-1H-imidazole

Conditions
ConditionsYield
With water; AP-64k at 330℃; for 0.6h; Product distribution; also in the molten state; var. temp. and contact time;
2,4-dimethyl-2-imidazoline
930-61-0

2,4-dimethyl-2-imidazoline

chloroform
67-66-3

chloroform

A

2,4-dimethylpyrimidine
14331-54-5

2,4-dimethylpyrimidine

B

4-chloro-2-methylpyrimidine
4994-86-9

4-chloro-2-methylpyrimidine

C

2-methylimidazole
693-98-1

2-methylimidazole

D

5-Chloro-2,4-dimethylpyrimidine
75712-73-1

5-Chloro-2,4-dimethylpyrimidine

Conditions
ConditionsYield
at 550℃; Yield given. Further byproducts given. Yields of byproduct given. Title compound not separated from byproducts;
2,4-dimethyl-2-imidazoline
930-61-0

2,4-dimethyl-2-imidazoline

chloroform
67-66-3

chloroform

A

2,5-dimethyl-pyrazine
123-32-0

2,5-dimethyl-pyrazine

B

4-chloro-2-methylpyrimidine
4994-86-9

4-chloro-2-methylpyrimidine

C

2-methylimidazole
693-98-1

2-methylimidazole

D

5-Chloro-2,4-dimethylpyrimidine
75712-73-1

5-Chloro-2,4-dimethylpyrimidine

Conditions
ConditionsYield
at 550℃; Yield given. Further byproducts given. Yields of byproduct given. Title compound not separated from byproducts;
2,4-dimethyl-2-imidazoline
930-61-0

2,4-dimethyl-2-imidazoline

chloroform
67-66-3

chloroform

A

4-chloro-2-methylpyrimidine
4994-86-9

4-chloro-2-methylpyrimidine

B

4-chloro-2,6-dimethylpyrimidine
4472-45-1

4-chloro-2,6-dimethylpyrimidine

C

2-methylimidazole
693-98-1

2-methylimidazole

D

5-Chloro-2,4-dimethylpyrimidine
75712-73-1

5-Chloro-2,4-dimethylpyrimidine

Conditions
ConditionsYield
at 550℃; Yield given. Further byproducts given. Yields of byproduct given;
2-methylimidazole
693-98-1

2-methylimidazole

4,5-diiodo-2-methyl-1H-imidazole
73746-44-8

4,5-diiodo-2-methyl-1H-imidazole

Conditions
ConditionsYield
With iodine; sodium carbonate In 1,4-dioxane; water at 20℃; for 24h;100%
With water; iodine; sodium carbonate In 1,4-dioxane at 20℃; for 24h; Iodination;98%
With iodine; silver(I) acetate In dichloromethane at 50℃; Inert atmosphere;93%
2-methylimidazole
693-98-1

2-methylimidazole

4-fluorobenzoyl chloride
403-43-0

4-fluorobenzoyl chloride

1-(p-fluorophenylcarbonyl)-2-methylimidazole
90172-64-8

1-(p-fluorophenylcarbonyl)-2-methylimidazole

Conditions
ConditionsYield
With 1,4-diaza-bicyclo[2.2.2]octane In chloroform-d1100%
2-methylimidazole
693-98-1

2-methylimidazole

1-oxo-11-(2'-chloroacetyl)-5,11-dihydro-6H-pyrido<2,3-b><1,4>benzodiazepin-6-one
84446-19-5

1-oxo-11-(2'-chloroacetyl)-5,11-dihydro-6H-pyrido<2,3-b><1,4>benzodiazepin-6-one

1-oxo-5,11-dihydro-11-(2''-methylimidazol-1''-yl)acetyl-6H-pyrido<2,3-b><1,4>benzodiazepin-6-one
84446-13-9

1-oxo-5,11-dihydro-11-(2''-methylimidazol-1''-yl)acetyl-6H-pyrido<2,3-b><1,4>benzodiazepin-6-one

Conditions
ConditionsYield
In toluene at 80℃; for 2h;100%
2-chloropyrimidine
1722-12-9

2-chloropyrimidine

2-methylimidazole
693-98-1

2-methylimidazole

2-(2-methyl-1H-imidazol-1-yl)pyrimidine

2-(2-methyl-1H-imidazol-1-yl)pyrimidine

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride; 2-aminopyrimidine-4,6-diol; copper(I) bromide at 145 - 150℃; for 24h;100%
With copper(I) oxide; 1,10-Phenanthroline; tetrabutyl ammonium fluoride at 140 - 145℃; for 24h;98%
Stage #1: 2-methylimidazole With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5h;
Stage #2: 2-chloropyrimidine In N,N-dimethyl-formamide; mineral oil at 130℃;
89%
With potassium phosphate; benzoin oxime; copper diacetate In dimethyl sulfoxide at 80℃; Inert atmosphere;80%
With copper; caesium carbonate; methyl-alpha-D-glucopyranoside In water; dimethyl sulfoxide at 110℃; for 14h; Sealed tube; Green chemistry;80%
2-methylimidazole
693-98-1

2-methylimidazole

trityl chloride
76-83-5

trityl chloride

2-methyl-1-tritylimidazole
23593-68-2

2-methyl-1-tritylimidazole

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;100%
With triethylamine In acetonitrile at 20℃; for 18.3333h;97%
With triethylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 2h;95%
C26H31ClN2O5S
403487-49-0

C26H31ClN2O5S

2-methylimidazole
693-98-1

2-methylimidazole

C29H33ClN4O2

C29H33ClN4O2

Conditions
ConditionsYield
Stage #1: 2-methylimidazole With sodium hydride In DMF (N,N-dimethyl-formamide) at 0 - 20℃; for 0.333333h;
Stage #2: C26H31ClN2O5S In DMF (N,N-dimethyl-formamide) at 20℃;
100%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

2-methylimidazole
693-98-1

2-methylimidazole

Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(H2O)2(2+)*2PF6(1-)=[Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(H2O)2](PF6)2

Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(H2O)2(2+)*2PF6(1-)=[Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(H2O)2](PF6)2

Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(C3H3N2CH3)2(2+)*2PF6(1-)=[Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(C3H3N2CH3)2](PF6)2

Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(C3H3N2CH3)2(2+)*2PF6(1-)=[Co((CHNN(CH3)C5H3N)2C5H2NC6H5)(C3H3N2CH3)2](PF6)2

Conditions
ConditionsYield
In methanol N2; Co comp. dissolved under reflux, to a soln. added an excess of ligand, refluxed for 25 min, a soln. of NH4PF6 added; ppt. filtered, washed copiously (diethyl ether), dried (vac.); elem. anal.;99%
2-methylimidazole
693-98-1

2-methylimidazole

[copper(I)(triphenylphosphine)4](perchlorate)
14741-28-7

[copper(I)(triphenylphosphine)4](perchlorate)

[(triphenylphosphine)2(2-methylimidazole)2Cu]ClO4
182012-99-3

[(triphenylphosphine)2(2-methylimidazole)2Cu]ClO4

Conditions
ConditionsYield
In diethyl ether large excess of N-ligand, stirring for 3 h (pptn.); collection (filtration), washing (ether); elem. anal.;99%
2-methylimidazole
693-98-1

2-methylimidazole

Cu(C6H5C5H2N(C5H3NN(CH3)NCH)2)(H2O)2(2+)*2PF6(1-)=[Cu(C6H5C5H2N(C5H3NN(CH3)NCH)2)(H2O)2](PF6)2

Cu(C6H5C5H2N(C5H3NN(CH3)NCH)2)(H2O)2(2+)*2PF6(1-)=[Cu(C6H5C5H2N(C5H3NN(CH3)NCH)2)(H2O)2](PF6)2

[Cu(PhC5H2N(C5H3NN(CH3)NCH)2)(2-methylimidazole)](PF6)2

[Cu(PhC5H2N(C5H3NN(CH3)NCH)2)(2-methylimidazole)](PF6)2

Conditions
ConditionsYield
In methanol excess of N-compd. was added to hot MeOH soln. of Cu-complex, reflux for25 min, concd. MeOH soln. of NH4PF6 was added; ppt. was collected, washed with copious amt. of Et2O, dried in vac., elem. anal.;99%
2-methylimidazole
693-98-1

2-methylimidazole

chlorosulfuric acid 2,2,2-trichloroethyl ester
764-09-0

chlorosulfuric acid 2,2,2-trichloroethyl ester

2,2,2-trichloroethyl 2-methyl-1H-imidazole-1-sulfonate
1185733-66-7

2,2,2-trichloroethyl 2-methyl-1H-imidazole-1-sulfonate

Conditions
ConditionsYield
for 2h; Inert atmosphere;99%
In tetrahydrofuran at 0 - 20℃; for 16h;95%
In tetrahydrofuran at 0 - 20℃; Inert atmosphere;88%
2-methylimidazole
693-98-1

2-methylimidazole

2-Methylphenylboronic acid
16419-60-6

2-Methylphenylboronic acid

2-methyl-1-o-tolyl-1H-imidazole

2-methyl-1-o-tolyl-1H-imidazole

Conditions
ConditionsYield
Stage #1: With N,N,N,N,-tetramethylethylenediamine; copper(II) nitrate In methanol at 20℃; for 0.25h;
Stage #2: 2-methylimidazole; 2-Methylphenylboronic acid With oxygen In methanol at 20℃; under 760.051 Torr; for 24h;
99%
With Cu-exchanged fluoroapatite; air In methanol at 20℃; for 12h;87%
2-methylimidazole
693-98-1

2-methylimidazole

2-Methoxyphenylboronic acid
5720-06-9

2-Methoxyphenylboronic acid

1-(2-methoxyphenyl)-2-methyl-1H-imidazole

1-(2-methoxyphenyl)-2-methyl-1H-imidazole

Conditions
ConditionsYield
With N,N,N,N,-tetramethylethylenediamine; oxygen; copper(II) nitrate In methanol at 20℃; under 760.051 Torr; for 48h;99%
With Cu-exchanged fluoroapatite; air In methanol at 20℃; for 12h;89%
2-methylimidazole
693-98-1

2-methylimidazole

2,4-dimethoxyphenylboronic acid
133730-34-4

2,4-dimethoxyphenylboronic acid

1-(2,4-dimethoxyphenyl)-2-methyl-1H-imidazole
1192014-98-4

1-(2,4-dimethoxyphenyl)-2-methyl-1H-imidazole

Conditions
ConditionsYield
With N,N,N,N,-tetramethylethylenediamine; oxygen; copper(II) nitrate In methanol at 20℃; under 760.051 Torr; for 48h;99%
With Cu-exchanged fluoroapatite; air In methanol at 20℃; for 10h;92%
2-methylimidazole
693-98-1

2-methylimidazole

4-chloro-8-hydroxy-2-methylquinoline
28507-46-2

4-chloro-8-hydroxy-2-methylquinoline

2-methyl-4-(2-methyl-imidazol-1-yl)-quinolin-8-ol
54666-30-7

2-methyl-4-(2-methyl-imidazol-1-yl)-quinolin-8-ol

Conditions
ConditionsYield
In 1,4-dioxane for 28h; Reflux;99%
2-methylimidazole
693-98-1

2-methylimidazole

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

2-methyl-1-(phenylsulfonyl)-1H-imidazole
1352921-06-2

2-methyl-1-(phenylsulfonyl)-1H-imidazole

Conditions
ConditionsYield
In dichloromethane at 0 - 20℃;99%
In dichloromethane at 0℃; for 5h; Inert atmosphere;97%
2-methylimidazole
693-98-1

2-methylimidazole

diethyl chlorophosphate
814-49-3

diethyl chlorophosphate

O,O-diethyl (2-methyl-1H-imidazol-1-yl)phosphonate
1384485-94-2

O,O-diethyl (2-methyl-1H-imidazol-1-yl)phosphonate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 26℃; for 0.333333h;99%
2-methylimidazole
693-98-1

2-methylimidazole

benzyl bromide
100-39-0

benzyl bromide

N-benzyl-2-methylimidazole
13750-62-4

N-benzyl-2-methylimidazole

Conditions
ConditionsYield
Stage #1: 2-methylimidazole With sodium hydride at -0.16℃; Schlenk technique; Inert atmosphere;
Stage #2: benzyl bromide In tetrahydrofuran Inert atmosphere; Schlenk technique; Reflux;
99%
With sodium hydroxide In water at 20℃; for 0.333333h; Temperature; Micellar solution;93%
With potassium carbonate In acetonitrile at 70℃;
2-methylimidazole
693-98-1

2-methylimidazole

phenylacetylene
536-74-3

phenylacetylene

(Z)-2-methyl-1-styryl-1H-imidazole
1198306-57-8

(Z)-2-methyl-1-styryl-1H-imidazole

Conditions
ConditionsYield
With potassium phosphate In dimethyl sulfoxide at 120℃; for 24h; Inert atmosphere; Schlenk technique; stereoselective reaction;99%
With potassium hydroxide In dimethyl sulfoxide at 120℃; for 3h; Schlenk technique; Inert atmosphere; stereoselective reaction;75%
2-methylimidazole
693-98-1

2-methylimidazole

3'-O-benzoyl-2'-deoxythymidine-5'-monophosphate triethylammonium salt

3'-O-benzoyl-2'-deoxythymidine-5'-monophosphate triethylammonium salt

3’-O-benzoyl-2’-deoxythymidine-5’-phosphor-2-methylimidazolide

3’-O-benzoyl-2’-deoxythymidine-5’-phosphor-2-methylimidazolide

Conditions
ConditionsYield
With 2,2'-dipyridyldisulphide; triethylamine; triphenylphosphine In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere;98.9%
2-methylimidazole
693-98-1

2-methylimidazole

crotonic acid methyl ester
623-43-8

crotonic acid methyl ester

methyl 3-(2-methyl-1H-imidazol-1-yl)butanoate

methyl 3-(2-methyl-1H-imidazol-1-yl)butanoate

Conditions
ConditionsYield
In neat (no solvent) at 80℃; for 24h; Michael Addition; Schlenk technique; Sealed tube;98.5%
2-methylimidazole
693-98-1

2-methylimidazole

1-(2’-O-benzoyl-α-L-threofuranosyl)thymidine-3’-monophosphate

1-(2’-O-benzoyl-α-L-threofuranosyl)thymidine-3’-monophosphate

1-(2’-O-benzoyl-α-L-threofuranosyl)thymidine-3’-monophosphor-2-methylimidazolide

1-(2’-O-benzoyl-α-L-threofuranosyl)thymidine-3’-monophosphor-2-methylimidazolide

Conditions
ConditionsYield
With 2,2'-dipyridyldisulphide; triethylamine; triphenylphosphine In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere;98.3%

693-98-1Relevant articles and documents

Identification of Intermediates and Products of 2,4,6-Trimethyl-1,3,5-Hexahydrotriazine Trihydrate and Glyoxal Reaction in an Aqueous Solution by NMR Spectroscopy

Bakibaev, A. A.,Cheltygmasheva, R. S.,Fateev, A. V.,Kotelnikov, O. A.,Kotov, A. V.,Tuguldurova, V. P.,Vodyankina, O. V.

, p. 225 - 231 (2020)

In situ formation of 2-methylimidazole as a result of 2,4,6-trimethyl-1,3,5-hexahydrotriazine trihydrate and glyoxal interaction in an aqueous solution is studied for the first time using NMR spectroscopy. In addition to the reactants and products, the reaction mixture is shown to contain stable intermediate products of the trimer decomposition as well as glycolic acid.

Imprinted Apportionment of Functional Groups in Multivariate Metal-Organic Frameworks

Feng, Liang,Wang, Kun-Yu,Lv, Xiu-Liang,Powell, Joshua A.,Yan, Tian-Hao,Willman, Jeremy,Zhou, Hong-Cai

supporting information, p. 14524 - 14529 (2019/10/02)

Sophisticated chemical processes widely observed in biological cells require precise apportionment regulation of building units, which inspires researchers to develop tailorable architectures with controllable heterogeneity for replication, recognition and information storage. However, it remains a substantial challenge to endow multivariate materials with internal sequences and controllable apportionments. Herein, we introduce a novel strategy to manipulate the apportionment of functional groups in multivariate metal-organic frameworks (MTV-MOFs) by preincorporating interlocked linkers into framework materials. As a proof of concept, the imprinted apportionment of functional groups within ZIF-8 was achieved by exchanging imine-based linker templates with original linkers initially. The removal of linker fragments by hydrolysis can be achieved via postsynthetic labilization, leading to the formation of architectures with controlled heterogeneity. The distributions of functional groups in the resulting imprinted MOFs can be tuned by judicious control of the interlocked chain length, which was further analyzed by computational methods. This work provides synthetic tools for precise control of pore environment and functionality sequences inside multicomponent materials.

Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors

Guo, Jing,Zhao, Fan,Yin, Wenbo,Zhu, Mingyue,Hao, Chenzhou,Pang, Yu,Wu, Tianxiao,Wang, Jian,Zhao, Dongmei,Li, Haitao,Cheng, Maosheng

, p. 197 - 209 (2018/06/12)

We have previously described the identification of indolin-2-one-5-carboxamides as potent PAK4 inhibitors. This study expands the structure-activity relationships on our original series by presenting several modifications in the lead compounds, 2 and 3. A series of novel derivatives was designed, synthesized, and evaluated in biochemical and cellular assay. Most of this series displayed nanomolar biochemical activity and potent antiproliferative activity against A549 and HCT116 cells. The representative compound 10a exhibited excellent enzyme inhibition (PAK4 IC50 = 25 nM) and cellular potency (A549 IC50 = 0.58 μM, HCT116 IC50 = 0.095 μM). An X-ray structure of compound 10a bound to PAK4 was obtained. Crystallographic analysis confirmed predictions from molecular modeling and helped refine SAR results. In addition, Compound 10a displayed focused multi-targeted kinase inhibition, good calculated drug-likeness properties. Further profiling of compound 10a revealed it showed weak inhibitory activity against various isoforms of human cytochrome P450.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 693-98-1